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that an R8-specific reporter of melted expression is lost
when Warts is overexpressed and that expression of a
warts enhancer trap is lost when Melted is overex-
pressed throughout the retina.
The opposite phenotypes of warts and melted al-
lowed the authors to examine the epistatic relationship
of these two genes. R8 cells double mutant for warts
and melted express Rhodopsin5, whereas R7 cells still
expressed either Rhodopsin 3 or Rhodopsin 4 demon-
strating the uncoupling of R7 and R8 subtypes by loss
of warts and melted. These genetic data indicated that
warts acts downstream of melted and that melted is
not necessary for R8 subtype determination.
Since Warts and Melted are both members of estab-
lished growth control pathways [Warts/Salvador/Hippo/
Mats and insulin receptor (InR)/Tor, respectively], the
authors tested if these pathways can regulate R8 sub-
types. Significantly, loss of salvador or hippo pheno-
copies loss of warts, indicating that this complex (pre-
viously known for its ability to regulate proliferation and
apotosis) controls p/y decisions. In contrast, loss of
components of the InR/Tor pathway does not affect
Rhodopsin expression in R8. These data suggest that
the mechanism of action of Melted in postmitotic cells
may be independent of its previously characterized
function in growth (Teleman et al., 2005). It will be inter-
esting to see whether the recently discovered gene Yor-
kie (Huang et al., 2005), a transcriptional corepressor
that is a target of the Warts/Salvador/Hippo complex,
also controls R8 subtype specification.
The data provide new insight into the genes con-
trolling ommatidial subtype, and are a lovely example
of how fate determination is established and cemented
in development. Equally interesting is the discovery of
a novel role for genes previously known to regulate
growth and proliferation, in the differentiation of post-
mitotic cells, an emerging theme in neuronal develop-
ment (Bateman and McNeill, 2004).
Of course many interesting questions remain to be
answered. How does the R7 cell decide to be y or p?
How is this decision communicated to the R8 cell? How
does warts control rhodopsin expression? The answers
are sure to be interesting, warts and all.
Joseph M. Bateman and Helen McNeill
Samuel Lunenfeld Research Institute
Toronto, Canada, M5G 1X5
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Our understanding of roles for the E2F transcription
factor in regulating apoptosis has progressed from
asking what E2F can do based on overexpression
studies to what E2F actually does based on analyses
of loss-of-function mutants. A paper in this issue of
Developmental Cell implicates Drosophila E2F1 in
context-dependent pro- as well as anti-apoptotic roles
in the same tissue following genotoxic stress.
For more than a decade E2F has been recognized as
an important regulator of cell cycle progression and as
a critical downstream target of the retinoblastoma tu-
mor suppressor protein (Rb). For almost as long, we
have understood that E2F activity can also promote
apoptosis, and numerous studies have explored how
the apoptotic functions of this important cell cycle reg-
ulator are controlled. These studies have contributed to
a scenario whereby E2F can control the cellular deci-
sion to either divide or die dependent on context, such
as influenced by the presence of DNA damage. A paper
by Moon, Dyson, and colleagues in this issue (Moon
et al., 2005) makes important new contributions to our
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mnderstanding of physiological roles for E2F in the con-
rol of apoptosis in response to DNA damage, demon-
trating that E2F can function to either promote or
urprisingly prevent apoptosis in the Drosophila mela-
ogaster wing disc dependent on the cell type.
E2F activity controls the transcription of a large num-
er of genes with roles in cell cycle phase transitions,
NA synthesis, mitosis, apoptosis, DNA repair and
heckpoints, as well as unexpected targets involved in
ifferentiation and development (Attwooll et al., 2004;
imova and Dyson, 2005). Mammalian E2F transcrip-
ional activity is encoded by eight E2F family member
enes, with E2Fs 1 through 6 functioning as hetero-
imers with the products of one of two DP genes. E2Fs
and 8 regulate transcription independently of the DP
artner. The Drosophila genome possesses only two
2F, one DP, and two Rb genes (Dimova and Dyson,
005). Drosophila E2F1 (dE2F1) functions similarly to
he mammalian E2Fs 1–3 that function primarily as tran-
criptional activators, and dE2F2 is more similar to
2Fs 4 and 5 which are more associated with repres-
ion, although this breakdown is probably an oversim-
lification. dE2F2 appears to function in opposition to
E2F1, and the loss of dE2F2 suppresses the prolifera-
ion defects and early larval lethality observed in dE2F1
utants.
Overexpression of mammalian E2F1 can result in
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443apoptosis involving the p53 and/or p73 pathways, and
E2F1 knockout mice exhibit defects in the apoptotic
negative selection of developing T cells (Attwooll et al.,
2004; Dimova and Dyson, 2005). E2F’s apoptotic role
appears conserved, as transgenic expression of dE2F1
results in increased apoptosis in Drosophila. Since
E2F1 appears to be upregulated during every cell cycle
entry, an important question has been how E2F1 func-
tion is modulated to control its apoptotic potential. In
this regard, phosphorylation of E2F1 by ataxia-telangi-
ectasia-mutated (ATM) and ataxia-telangiectasia and
Rad3-related (ATR) kinases, as well as by checkpoint
kinase 2 (Chk2), increases E2F1 stabilization and activ-
ity following DNA damage (Attwooll et al., 2004). Upreg-
ulated E2F1 activity can also promote the stabilization
and activation of p53, which is dependent on ATM and
Chk2 activities. Finally, E2F4 is replaced by E2F1 on the
p73 promoter following DNA damage, which appears
dependent on acetylation of E2F1 (Pediconi et al.,
2003). While far from established, DNA damage path-
way-dependent alterations in E2F1 and its interactions
with other transcriptional regulators may favor E2F1-
dependent activation of proapoptotic effectors over
cell cycle effectors.
Contrasting roles for E2F1 in the control of DNA dam-
age-induced apoptosis have been described by studies
of E2F1−/− cells and mice. E2F1−/− thymocytes exhibit
decreased apoptosis in response to etoposide treat-
ment in vitro (Lin et al., 2001), although other studies
found no effect of E2F1 loss on γ irradiation or adria-
mycin-induced thymocyte apoptosis in vivo or in vitro
(Wikonkal et al., 2003; Zhu et al., 1999). While less well
established, experiments have indicated prosurvival
functions of E2F1. E2F1−/− and E2F1 overexpressing
transgenic mouse keritinocytes exhibit enhanced and
diminished, respectively, apoptosis in vivo in response
to ultraviolet light (UV) (Berton et al., 2005; Wikonkal et
al., 2003), perhaps dependent on the requirement for
E2F1 in the repair of UV-induced DNA adducts. How-
ever, E2F1 loss did not potentiate apoptosis following
exposure of fibroblasts or keritinocytes to UV in vitro,
although E2F1 loss did restore apoptosis in p53−/− cells
(Wikonkal et al., 2003). Most strikingly, in this study
E2F1 null mutation substantially suppressed tumor for-
mation in p53−/− mice. Still, a second group reported
no effect of E2F1 loss on cancer rates in p53−/− mice,
and the reasons for this major discrepancy have not
been elucidated (Wloga et al., 2004).
Previous studies using the Drosophila model system
have shown that UV-C-induced apoptosis requires
dE2F1 and Hac-1 (APAF-1 homolog), which is itself E2F
regulated, in pregastrulation embryos (Zhou and Steller,
2003). In contrast, in midstage embryos mei-41 (ATM/
ATR homolog), but not dE2F1, is required for UV-C-
induced apoptosis. Thus, the stage of development can
determine the dependence of apoptosis on particular
pathways, and at least in these settings E2F and ATM/
ATR do not appear to function in the same pathway.
When different groups demonstrate opposite roles
for E2F in cell survival, the discrepancy is often rational-
ized as context- or model-dependent. Certainly, dif-
ferent types of DNA damage can activate different re-
sponse pathways, and the cell type examined will
influence the dependency on different effectors likeE2F1. The paper by Moon, Dyson, and colleagues nicely
supports both proapoptotic and prosurvival roles for
Drosophila E2F within individual developing wing discs
exposed to γ irradiation (Moon et al., 2005). Irradiation
of third instar larvae results in cell cycle arrest through-
out the wing disc and substantial apoptosis in the
highly proliferative region containing intervein cells. In
contrast, the dorsal/ventral (D/V) boundary, a zone of
nonproliferating cells, is mostly protected from radia-
tion-induced apoptosis. Both the increased apoptosis
in intervein cells and the survival of D/V cells require
dE2F1 and dDP1. As normal and irradiation-induced
cell cycle patterns, as well as wing disc development,
were not affected in dDP mutants, the altered apoptotic
patterns do not indirectly result from cell cycle or de-
velopmental differences. Analyses of partial loss-of-
function alleles of de2f1 and mutant clones of rbf1
(Drosophila Rb) provided more insight, showing that (1)
pro- and antiapoptotic roles are determined by dE2F1,
not dE2F2, dependent on its transactivation domain,
and (2) intervein cell apoptosis appears to be mediated
by dE2F1-dependent transcriptional activation, while
D/V boundary cell survival is dependent on Rbf1/dE2F1/
dDP complexes. While dE2F1/dDP appears to protect
nonproliferating cells and sensitize proliferating cells to
γ irradiation-induced apoptosis, there are clearly other
factors, perhaps including the Ras and Notch path-
ways, which modify apoptotic sensitivity.
Finally, the authors provide evidence that basal ex-
pression of the proapoptotic hid gene in D/V cells is
directly inhibited by dE2F1, providing insight into how
dE2F1 protects the D/V cells from apoptosis. Reduced
expression of the proapoptotic hid gene prevents the
ectopic apoptosis in the D/V region following DNA
damage in dDP mutant larvae. dE2F1-dependent re-
pression of the hid gene via an E2F binding site at −1.4
kb in the promoter is unconventional, and it will be im-
portant to uncover how Rbf/dE2F1 complexes interact
with other transcription factors to mediate repression.
In total, this paper establishes physiological roles for
E2F activity in regulating cell death and survival deci-
sions in response to DNA damage, defining a prosur-
vival function of E2F upstream of Hid.
As has become cliché to write in previews, open
questions remain. What are the developmental and cell
type-specific cues that modulate E2F’s apoptotic po-
tential? Does the spectrum of E2F1 target gene regula-
tion change following genotoxic stress, and how could
such a transcriptional switch be controlled? And finally,
does E2F1 play an important role in DNA damage re-
sponses in humans, particularly during tumor suppres-
sion or cellular responses to radio- and chemothera-
peutics? Apoptosis in response to DNA damage is
important for the elimination of damaged cells to pre-
vent the propagation of induced mutations, which can
contribute to cancer initiation. The differential sensitiv-
ity of cancer cells relative to noncancer cells to geno-
toxic stress-induced cell death also in part underlies
the efficacy (or lack of) of radio- and chemotherapeu-
tics. Given the very frequent deregulation of E2F activ-
ity in human cancers, understanding how E2F modu-
lates apoptotic sensitivity and how context (cell type,
type of damage, etc.) determines E2F’s role as a pro-
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444moter or inhibitor of apoptosis will be important for the
improved design of cancer therapies.
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